Chembio launched a rapid test, cleared for emergency use by the FDA, that can differentiate between COVID-19 and influenza Type A and Type B. Chembio Diagnostics (CEMI) shares spiked on Monday as the ...

The sale of Chembio Diagnostics Inc. in Medford and Bay Shore to a French firm has finally been completed, the companies announced this week. A slim majority of 50.9% of Chembio shares were tendered ...

MEDFORD, N.Y., Nov. 04, 2019 (GLOBE NEWSWIRE) -- November 4, 2019 - Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today ...

(RTTNews) - Shares of Chembio Diagnostics, Inc. (CEMI) are falling more than 17% Friday morning at $6.17. In an SEC filing on Thursday the company reported that the FDA is not prioritizing the ...

A manufacturer of rapid diagnostic tests in Hauppauge has paid $500,000 to end an investigation by the U.S. Securities and Exchange Commission, according to a securities filing. Chembio Diagnostics ...

HAUPPAUGE, N.Y., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission to the U ...

HAUPPAUGE, N.Y., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt on ...

Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 2020 and June 16, 2020, ...